BFC Planning’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
BFC Planning's ASND Position: Q3 2026 in Review
BFC Planning reduced its Ascendis Pharma (ASND) stake by 16% in Q3 2026, selling an estimated $34.4K and leaving 692 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #1029.
BFC Planning first reported a position in ASND in Q3 2025 and has held it in 5 quarters since. The position peaked at $221K in Q2 2026. 255 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- BFC Planning held 692 shares of Ascendis Pharma worth $158K as of Q3 2026.
- BFC Planning sold 136 Ascendis Pharma shares in Q3 2026, an estimated $34.4K.
- Ascendis Pharma made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1029 holding.
- BFC Planning first reported a position in Ascendis Pharma in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Ascendis Pharma position peaked at $221K in Q2 2026.
- 255 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.